TickerFactsScreenerDevelopers

Larimar Therapeutics, Inc. (LRMR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $2.0K2013: $17.0K2014: $58.0K2015: $595.0K2016: $660.0K2017: $55.0K2018: $108.0K2019: $83.0K2020: $62.0K2021: $333.0K2022: $100.0K2023: $164.0K2024: $515.0K2025: $91.0K$91.0K
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$91.0K-82.3%
2024$515.0K+214.0%
2023$164.0K+64.0%
2022$100.0K-70.0%
2021$333.0K+437.1%
2020$62.0K-25.3%
2019$83.0K-23.1%
2018$108.0K+96.4%
2017$55.0K-91.7%
2016$660.0K+10.9%
2015$595.0K+925.9%
2014$58.0K+241.2%
2013$17.0K+750.0%
2012$2.0K—